Unleashing the Potential of Cannabis Terpenes: The Next Phase of the Cannabis Revolution – If the legalization of cannabis marked the first phase of the cannabis revolution, the second phase could be driven by the exploration of terpenes and other lesser-studied components of the plant. With the recent exemption of cannabis from the federal Controlled Substances Act in the US, allowing for more research into its medical potential, prestigious science institutions are now focusing on studying cannabis terpenes and their role in future treatments for various conditions. This article highlights the significance of terpenes in the cannabis industry, both in terms of medical advancements and commercial opportunities.

Cannabis Terpenes – A Prominent Research Topic:

Previously hindered by the Schedule I classification, cannabis research has experienced a significant breakthrough with the declassification of marijuana and the removal of red tape around cannabis research. Prominent US research bodies, including national institutes for aging, drug abuse, alcohol abuse, and cancer, are now poised to promote in-depth analysis of minor cannabinoids and cannabis terpenes. These studies aim to unravel the therapeutic pathways of terpenes and explore their potential applications in various areas such as analgesia, Alzheimer’s disease, alcohol abuse, cancer care, dentistry, epilepsy, migraines, strokes, and substance abuse.

Enhancing Cannabis Products through Terpene Knowledge:

While the therapeutic mechanisms of action behind terpenes are still being investigated, the cannabis industry recognizes the untapped commercial benefits they offer. In-depth analysis of the approximately 150 identified cannabis terpenes allows growers and producers to manufacture products that cater to specific beneficial effects, including anxiety relief and improved sleep. Evidence suggests that terpenes enhance pain relief, and their combination with cannabidiol (CBD) shows promise in treating inflammatory conditions, including those triggered by Covid-19. Moreover, terpene analysis enables the customization of terpene profiles to meet consumer preferences, leading to enhanced recreational cannabis experiences and consistent quality. It also helps address allergen concerns for customers sensitive to specific terpenes.

The Role of Terpene Reference Materials:

Determining the exact terpene profile of cannabis products requires precise laboratory analysis due to variations in growing and curing techniques. Headspace gas chromatography (HS-GC) coupled with a mass spectrometer is widely used for terpene analysis, offering accurate detection levels required by cannabis testing laboratories. The use of reference materials becomes essential in this process, aiding analytical chemists in establishing the presence and concentration of desired terpenes. By ensuring customer satisfaction and the potential effectiveness of medicinal products, reference materials contribute to reliable and high-quality analysis.

Introducing TerpiMix: A Breakthrough in Terpene Analysis:

Dr Ehrenstorfer presents TerpiMix, a groundbreaking solution for terpene analysis. TerpiMix is a comprehensive testing kit designed to screen 63 terpene analytes in cannabis and food products, revolutionizing laboratory analysis. With ISO 17034 accreditation, TerpiMix guarantees the highest possible quality and enables laboratories to focus on analysis rather than calibration. To enhance clarity and optimal elution, unnecessary analytes have been removed, resulting in clearly defined results. TerpiMix is accompanied by three new terpene mixtures (652, 653, and 654), all designed for extended shelf life and available for individual purchase or as part of a kit.


As the cannabis revolution continues, the exploration of terpenes emerges as the next pivotal phase. Unlocking the therapeutic potential of terpenes through scientific research and advanced analytical techniques will pave the way for targeted, authentic, and data-driven health and wellness solutions. Furthermore, terpene analysis empowers growers and manufacturers to create tailored cannabis products, meeting both medicinal and recreational demands while ensuring consistent quality

CWS Abroad is an LGC Standard distributor and provides Dr. Ehrenstorfer. You can also follow us on Linkedin and Instagram for advice and information on running your lab.